Reflections on the question: What does molecular mycology have to do with the clinician treating the patient?

References

• Chang HC, Leaw SN, Huang AH, Wuk TL, Chang TC. Rapid identification of yeasts in positive blood cultures by a multiplex PCR method. J Clin Microbiol 2001; 39: 3466–3471.
   Google Scholar
• Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Cole-man DC. Candida dubliniensis sp nov: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141: 1507–1521.
   Google Scholar
• Fisher MC, Koenig GL, White TJ, Taylor JT. Molecular and phenotypic description of Coccidioides posadasii sp nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 2002; 94: 73–84.
   Google Scholar
• Soil DT. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 2000; 13: 332–370.
   PubMed Web of Science ®Google Scholar
• Maiden MU, Bygraves JA, Feil E, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998; 95: 3140–3145.
   PubMed Web of Science ®Google Scholar
• Bougnoux M-E, Morand S, D'enfert C. Usefulness of multilocus sequence typing for characterization of clinical isolates of Candida albi cans. J Clin Microbiol 2002; 40: 1290–1297.
   Google Scholar
• Lass-Florl C, Aigner J, Gunsilius E, et al. Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies. Br J Haematol 2001; 113: 180–184.
   Google Scholar
• Kami M, Fukui T, Ogawa S, et al. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 2001; 33: 1504–1512.
   PubMed Web of Science ®Google Scholar
• Horrobin DF. Innovation in the pharmaceutical industry. J Roy Soc Med 2000; 93: 341–345.
   PubMedGoogle Scholar
• Odds FC. Are molecular methods the optimum route to antimicrobial drugs? In: Andrew PW, Oyston P, Smith GL, Stewart-Tull DE, eds Fighting Infection in the 21st Century. Oxford: Blackwell Science Ltd; 2000: 237–258.
   Google Scholar
• Odds FC. Sordarin antifungal agents. Expert Opin Ther Patents 2001; 11: 283–294.
   Web of Science ®Google Scholar
• Tomee JFC, Kauffman HF. Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 2000; 30: 476–484.
   Google Scholar
• Latge JP. Aspergillus fumigatus and aspergillosis. Gun Microbiol Rev 1999; 12: 310–350.
   PubMed Web of Science ®Google Scholar
• Retallack DM, Heinecke EL, Gibbons R, Deepe GS, Woods JP. The URA5 gene is necessary for Histoplasma capsulatum growth during infection of mouse and human cells. Infect Immun 1999; 68: 624–629.
   Google Scholar
• Chang YC, Penoyer LA, Kwon-Chung KJ. The second STE12 homologue of Cryptococcus neoformans is MATa- specific and plays an important role in virulence. Proc Natl Acad Sci USA 2001; 98: 3258–3263.
   Google Scholar
• Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR. Urease as a virulence factor in experimental cryptococcosis. Infect Immun 2000; 68: 443–448.
   Google Scholar
• Wills EA, Roberts IS, Del Poeta M, et al. Identification and characterization of the Cryptococcus neoformans phosphoman-nose isomerase-encoding gene, MANI, and its impact on pathogenicity. Mol Microbiol 2001; 40: 610–620.
   PubMed Web of Science ®Google Scholar
• Klein BS. Molecular basis of pathogenicity in Blastomyces dermatitidis: the importance of adhesion. Curr Opin Microbiol 2000; 3: 339–343.
   PubMed Web of Science ®Google Scholar
• Retallack DM, Deepe GS, Woods JP. Applying in vivo expression technology (IVET) to the fungal pathogen Histo-plasma capsulatum. Microb Pathog 2000; 28: 169–182.
   Google Scholar
• Brown JS, Aufauvre-Brown A, Brown J, et al. Signature-tagged and directed mutagenesis identify PABA synthetase as essential for Aspergillus fumigatus pathogenicity. Mol Microbiol 2000; 36: 1371–1380.
   PubMed Web of Science ®Google Scholar
• Nelson RT, Hua J, Pryor B, Lodge JK. Identification of virulence mutants of the fungal pathogen Cryptococcus neofor-mans using signature-tagged mutagenesis. Genetics 2001; 157: 935–947.
   PubMed Web of Science ®Google Scholar
• Colonna-Romano S, Porta A, Franco A, Kobayashi GS, Maresca B. Identification and isolation by DDRT-PCR of genes differentially expressed by Histoplasma capsulatum during macrophages infection. Microb Pathog 2000; 25: 55–66.
   Google Scholar
• Navarro-Garcia F, Sanchez M, Nombela C, Pla J. Virulence genes in the pathogenic yeast Candida albi cans. FEMS Microbiol Rev 2001; 25: 245–268.
   Google Scholar
• Lay J, Henry LK, Clifford J, et al. Altered expression of selectable marker ura3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect Immun 1998; 66: 5301–5306.
   PubMedGoogle Scholar
• Brem RB, Yvert G, Clinton R, Kruglyak L. Genetic dissection of transcriptional regulation in budding yeast. Science 2002; 296: 752–755.
   PubMed Web of Science ®Google Scholar
• Deepe GS, Romani L, Calich VLG, et al. Knockout mice as experimental models of virulence. Med Mycol 2000; 38: 87–98.
   PubMed Web of Science ®Google Scholar